An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers

被引:11
|
作者
Rusbridge, Clare [1 ,2 ]
Salguero, Francisco J. [1 ]
David, Monique Antoinette [3 ]
Faller, Kiterie M. E. [4 ]
Bras, Jose T. [5 ,6 ,7 ]
Guerreiro, Rita J. [5 ,6 ,7 ]
Richard-Londt, Angela C. [8 ,9 ]
Grainger, Duncan [1 ]
Head, Elizabeth [10 ]
Brandner, Sebastian G. P. [8 ,9 ]
Summers, Brian
Hardy, John
Tayebi, Mourad [1 ,3 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Pathol & Infect Dis, Guildford, Surrey, England
[2] Fitzpatrick Referrals, Godalming, Surrey, England
[3] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
[4] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
[5] UCL, Inst Neurol, Dept Mol Neurosci, London, England
[6] Univ Aveiro, Dept Med Sci, Aveiro, Portugal
[7] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal
[8] UCL, Inst Neurol, Div Neuropathol, London, England
[9] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England
[10] Univ Kentucky, Sanders Brown Ctr Aging, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA
来源
关键词
canine cognitive dysfunction; Alzheimer; canine; A beta oligomers; neuropathology; aggregation; neurotoxicity; ALZHEIMERS-DISEASE; BRAIN; DOGS; ANTIBODIES; PROTEINS; PATHWAY; MODEL;
D O I
10.3389/fnagi.2018.00007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mirrored in the naturally occurring age-associated neuropathology in the canine species. In aged dogs with declining learned behavior and memory the severity of cognitive dysfunction parallels the progressive build up and location of A beta in the brain. The main aim of this work was to study the biological behavior of soluble oligomers isolated from an aged dog with cognitive dysfunction through investigating their interaction with a human cell line and synthetic A beta peptides. We report that soluble oligomers were specifically detected in the dog's blood and cerebrospinal fluid (CSF) via anti-oligomer-and anti-A beta specific binders. Importantly, our results reveal the potent neurotoxic effects of the dog's CSF on cell viability and the seeding efficiency of the CSF-borne soluble oligomers on the thermodynamic activity and the aggregation kinetics of synthetic human A beta. The value of further characterizing the naturally occurring Alzheimer-like neuropathology in dogs using genetic and molecular tools is discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Cerebrospinal Fluid Beta-Amyloid Concentration and Clinical and Radiographic Manifestations of Cerebral Amyloid Angiopathy
    Alten, Baris
    Gokcal, Elif
    Warren, Andrew
    van Veluw, Susanne J.
    Kozberg, Mariel
    Gurol, M. Edip
    Viswanathan, Anand
    Greenberg, Steven M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (05):
  • [22] Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta
    Oikonomidi, Aikaterini
    Lewczuk, Piotr
    Kornhuber, Johannes
    Smulders, Yvo
    Linnebank, Michael
    Semmler, Alexander
    Popp, Julius
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 (02) : 324 - 332
  • [23] Cerebrospinal fluid ratio of phosphorylated tau protein and beta amyloid predicts amyloid PET positivity
    Cerman, J.
    Laczo, J.
    Vyhnalek, M.
    Malinovska, J.
    Hanzalova, J.
    Hort, J.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (02) : 173 - 179
  • [24] SOLUBLE AMYLOID BETA-PROTEIN IS A MARKER OF ALZHEIMER AMYLOID IN BRAIN BUT NOT IN CEREBROSPINAL-FLUID
    TABATON, M
    NUNZI, MG
    XUE, R
    USIAK, M
    AUTILIOGAMBETTI, L
    GAMBETTI, P
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (03) : 1598 - 1603
  • [25] Amyloid-β Oligomers in Cerebrospinal Fluid are Associated with Cognitive Decline in Patients with Alzheimer's Disease
    Santos, Alexander Navarrete
    Ewers, Michael
    Minthon, Lennart
    Simm, Andreas
    Silber, Rolf-Edgar
    Blennow, Kaj
    Prvulovic, David
    Hansson, Oskar
    Hampel, Harald
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 29 (01) : 171 - 176
  • [26] Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid
    Rogeberg, Magnus
    Wettergreen, Marianne
    Nilsson, Lars N. G.
    Fladby, Tormod
    BIOCHIMIE, 2015, 113 : 86 - 92
  • [27] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
    Mandic, Gorana
    Markovic, Ivanka
    Ostojic, Marija
    Stojkovic, Tanja
    Misirlic-Dencic, Sonja
    Zivanovic-Radnic, Tatjana
    Stefanovic, Rodoljub
    Bumbasirevic, Marko
    Stefanova, Elka
    Kostic, Vladimir
    VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
  • [28] Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity
    Uttner, Ingo
    Schurig, Niklas
    von Arnim, Christine A. F.
    Lange-Asschenfeldt, Christian
    Brettschneider, Johannes
    Riepe, Matthias W.
    Tumani, Hayrettin
    PSYCHIATRY RESEARCH, 2011, 190 (01) : 132 - 136
  • [29] CHARACTERIZATION OF BETA-AMYLOID PEPTIDE FROM HUMAN CEREBROSPINAL-FLUID
    VIGOPELFREY, C
    LEE, D
    KEIM, P
    LIEBERBURG, I
    SCHENK, DB
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 (05) : 1965 - 1968
  • [30] SOLUBLE AMYLOID-BETA PROTEIN IS A MARKER OF ALZHEIMER AMYLOID IN THE BRAIN BUT PLOT IN CEREBROSPINAL-FLUID
    TABATON, M
    NUNZI, MG
    XUE, R
    AUTILIOGAMBETTI, L
    GAMBETTI, P
    NEUROLOGY, 1994, 44 (04) : A371 - A371